what is the cost of glp-1 drugs Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss How HR and Finance Leaders

Simonsen E, Lund LC, Ernst MT, et al

Nowowiejska J, Baran A, Flisiak I

Demand Outlook for GLP-1 Nutritional Support Market in the United States The CAGR of the GLP-1 nutritional support market in the United States rose from approximately 8.2% during 2020 to 2024 to 11.2% for 2025 to 2035, supported by stronger insurance reimbursement frameworks and physician adoption across outpatient metabolic care

Users of Brand-Name GLP-1s Report Slightly Lower Effectiveness Users of brand-name GLP-1 medications report slightly lower effectiveness than do users of compounded or custom-mixed versions, but both types of patients consider the drugs to be effective

Using themselves as subjects and RIA, they demonstrated that people experience higher insulin levels when they eat sugar than when it is injected into their bloodstream (McIntyre, Holdsworth, Turner)

Pyrazole-3-Carbohydrazone Analogs A series of new DPP-4 inhibitors featuring the pyrazole-3-carbohydrazone structure (39) were identified in work conducted by Deyan Wu et al